Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer

Cited by (216)

Items 201–216 of 216

1. Genetic Heterogeneity in Renal Cell Carcinoma: Clinical Implications?
   Susan A. J. Vaziri, Mahrukh K. Ganapathi, Ram N Ganapathi · 2014 · Springer eBooks
2. Additional file 1 of Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
   Fengzhi LI, Ieman A. M. Aljahdali, Zhang, Renyuan, Kent L. Nastiuk, John J. Krolewski, Xiang Ling · 2021 · Figshare
3. Additional file 1 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
   Ma, Xueyou, Zenglai Tan, Qin Zhang, Ma, Kaifang, Jun Xiao, Wang, Xiong, Wang, Yanan, Mengjie Zhong, Wang, Yu, Li, Jing et al. · 2022 · Figshare
4. Additional file 2 of Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer
   Louis Y. El Khoury, Fu, Shuang, Ryan A. Hlady, Ryan T. Wagner, Wang, Liguo, Eckel-Passow, Jeanette E., Erik P. Castle, Stanton, Melissa L., Thompson, R. Houston, Parker, Alexander S. et al. · 2021 · Figshare
5. Additional file 5 of Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs
   Arnaiz, Esther, Ana Miar, Esther Bridges, Naveen Prasad, Stephanie B. Hatch, Ebner, Daniel, Lawrie, Charles H., Adrian Llewellyn Harris · 2021 · Figshare
6. Additional file 1 of Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs
   Arnaiz, Esther, Ana Miar, Esther Bridges, Naveen Prasad, Stephanie B. Hatch, Ebner, Daniel, Lawrie, Charles H., Adrian Harris · 2021 · Figshare
7. Additional file 4 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
   Ma, Xueyou, Zenglai Tan, Zhang, Qin, Ma, Kaifang, Xiao, Jun, Wang, Xiong, Wang, Yanan, Mengjie Zhong, Wang, Yu, Li, Jing et al. · 2022 · Figshare
8. Additional file 6 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
   Ma, Xueyou, Zenglai Tan, Qin Zhang, Ma, Kaifang, Jun Xiao, Wang, Xiong, Wang, Yanan, Mengjie Zhong, Wang, Yu, Li, Jing et al. · 2022 · Figshare
9. Additional file 2 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
   Ma, Xueyou, Zenglai Tan, Qin Zhang, Ma, Kaifang, Jun Xiao, Wang, Xiong, Wang, Yanan, Mengjie Zhong, Wang, Yu, Li, Jing et al. · 2022 · Figshare
10. Additional file 5 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
    Ma, Xueyou, Zenglai Tan, Qin Zhang, Ma, Kaifang, Xiao, Jun, Wang, Xiong, Wang, Yanan, Mengjie Zhong, Wang, Yu, Li, Jing et al. · 2022 · Figshare
11. Additional file 3 of VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
    Ma, Xueyou, Zenglai Tan, Zhang, Qin, Ma, Kaifang, Xiao, Jun, Wang, Xiong, Wang, Yanan, Mengjie Zhong, Wang, Yu, Li, Jing et al. · 2022 · Figshare
12. MAGI3 deficiency unleashes β-catenin conformational change to drive metastatic progression and mTOR inhibitor resistance in ccRCC
    Siyu Gu, Haibo Wang, Hua Liu, Yumeng Yang, Yu Guo, Pengyan Fa, Lijie Zhang, Yang Yang, Xuan Qi, Qiong Qin et al. · 2026 · Cell Death and Disease
13. Pharmacogenomic and High-Throughput Data Analysis to Overcome Triple Negative Breast Cancers Drug Resistance
    Benjamin Sadacca · 2017 · theses.fr (ABES)
14. Racial and ethnic disparities in the cause of death for clear cell renal cell carcinoma
    Yingwei Xie, Yishan Zhang, Shuang Li, Li Chen, Yuexin Liu, Wenlian Xie, Zaosong Zheng, Hao Ping · 2026 · Nature Communications
15. A CTC/DTC-centered temporal framework of bone metastasis: From dissemination to dormancy and reactivation
    Zijie Yuan, Hao Zhang, Jingyu Xing, Xinghao Cao, Genkun Liu, Tao Tan, Chenglong Zhao, Cheng Yang · 2026 · Journal of bone oncology
16. Hypoxia-induced epigenetic reprogramming of cancer stem cells: Linking stemness, metastasis, and therapy resistance
    Mutaz Jamal Al‐Khreisat, Rustam Narzikulov, Omer Qutaiba B. Allela, Asyl Fatk Tmkyn, Priya Priyadarshini Nayak, Abdusamat Rasulov, Shamuratova Gulnora Baxtiyorovna, Neeraj Bainsal · 2026 · Gene